Everything below concerns cyclic heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-05-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
| Property | Value | Notes |
|---|---|---|
| Lyophilised storage | −20 °C, dry, protected from light | Vials are sealed and allowed to reach room temperature before opening |
| Reconstituted storage | 2 to 8 °C, protected from light | Short-term holding; avoid repeated freeze-thaw cycles |
| Reconstitution solvent | Water for injection or bacteriostatic water | Added slowly along the vial wall to reduce foaming and shear |
| Purity measurement | RP-HPLC with area normalisation | Acetonitrile-water gradient monitored at roughly 214 nm |
| Identity confirmation | Electrospray ionisation mass spectrometry | Observed mass compared against the calculated peptide mass |
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
=== More exotic types of decay === Other types of radioactive decay were found to emit previously seen particles but via different mechanisms. An example is internal conversion, which results in an initial electron emission, and then often further characteristic X-rays and Auger electrons emissions, although the internal conversion process involves neither beta nor gamma decay. A neutrino is not emitted, and none of the electron(s) and photon(s) emitted originate in the nucleus, even though the energy to emit all of them does originate there. Internal conversion decay, like isomeric transition gamma decay and neutron emission, involves the release of energy by an excited nuclide, without the transmutation of one element into another. Rare events that involve a combination of two beta-decay-type events happening simultaneously are known (see below). Any decay process that does not violate the conservation of energy or momentum laws (and perhaps other particle conservation laws) is permitted to happen, although not all have been detected. An interesting example discussed in a final section, is bound state beta decay of rhenium-187. In this process, the beta electron-decay of the parent nuclide is not accompanied by beta electron emission, because the beta particle has been captured into the K-shell of the emitting atom. An antineutrino is emitted, as in all negative beta decays. If energy circumstances are favorable, a given radionuclide may undergo many competing types of decay, with some atoms decaying by one route, and others decaying by another.
(CH2CH2)O + RCOCl + NaI → RC(O)–OCH2CH2–I + NaCl Heating ethylene oxide to 100 °C with carbon dioxide, in a non-polar solvent in the presence of bis-(triphenylphosphine)-nickel(0) results in ethylene carbonate:
STEP 2: The 2-methylpropanol-TPP is oxidized to form an acyl group while being simultaneously transferred to the lipoyl cofactor on E2. Note that TPP is regenerated. The proper arrow-pushing mechanism is shown in Figure 4.
== Cross-linking with hemoglobin-albumin == Disuccinimidyl suberate's reactivity toward primary amines allows it to serve as a cross-linking agent for proteins, without toxic side-products and forming peptide bonds with the lysine residues in a single step. In a study on blood substitutes, DSS was shown to cross-link Hemoglobin intramolecularly, yielding a relatively stable protein (polymerized Hb or polyHb), whose oxygen affinity was almost halved compared to that of native Hb. This was shown to be reversed when Hemoglobin was copolymerized with bovine serum albumin (BSA), showing very little change in auto-oxidation and oxygen affinity compared to the native Hb.
== Synthesis == In the female, relaxin is produced by the corpus luteum of the ovary, the breast and, during pregnancy, also by the placenta, chorion, and decidua. In the male, it is produced in the prostate and is present in human semen.
Sources: en.wikipedia.org
== Legacy == A Review of General Psychology survey, published in 2002, ranked Jung as the 23rd most cited psychologist of the 20th century. The list however focused on U.S. journals and was made by the psychology department of Arkansas State University. Although psychoanalysis is still studied in the humanities, a 2008 study in The Journal of the American Psychoanalytic Association found that psychology departments and textbooks treat it as "desiccated and dead". Similarly, Alan Stone noted, "As academic psychology becomes more 'scientific' and psychiatry more biological, psychoanalysis is being brushed aside."
Digital vaccine passports and vaccination certificates use software for verifying vaccination status. Such certificates were used to regulate access to events, buildings and services such as airplanes, concert venues and health clubs and travel across borders.
=== Changes in menus === To make MREs more palatable to service members and match ever-changing trends in popular tastes, the military is constantly seeking feedback to adjust MRE menus and ingredients. In the following list, only main entrees are listed. Vegetarian menus are marked and footnoted on their first appearance.
===== MeSH D08.811.682.608 – nadh, nadph oxidoreductases ===== MeSH D08.811.682.608.047 – apoptosis inducing factor MeSH D08.811.682.608.191 – cytochrome reductases MeSH D08.811.682.608.191.237 – cytochrome-b(5) reductase MeSH D08.811.682.608.191.500 – nadph-ferrihemoprotein reductase MeSH D08.811.682.608.504 – electron transport complex i MeSH D08.811.682.608.504.500 – nadh dehydrogenase MeSH D08.811.682.608.530 – nadh tetrazolium reductase MeSH D08.811.682.608.540 – nadp transhydrogenase MeSH D08.811.682.608.550 – nadph dehydrogenase MeSH D08.811.682.608.575 – nadph oxidase MeSH D08.811.682.608.800 – quinone reductases MeSH D08.811.682.608.800.500 – nad(p)h dehydrogenase (quinone) MeSH D08.811.682.608.800.500.500 – zeta-crystallins
== Discovery == Since the 1960s, seryl-tRNA synthetases have been described in various eukaryotic species, in both biochemical and structural analyses. It was not until 1997 that human SARS and its enzyme product were isolated and expressed in Escherichia coli by a team from The European Molecular Biology Laboratory in France.
Sources: en.wikipedia.org
4-Methyl sterols are intermediates in the biosynthesis of 4-desmethyl sterols and are known to accumulate under anaerobic conditions. The synthesis of dinosterol begins with the cyclization of squalene to lanosterol, but then diverges from cholesterol biosynthesis. The biosynthesis of dinosterol's side chain has been investigated in dinoflagellates using methionine-[CD3]. The sequence of side-chain alkylations is thought to be initiated by the formation of 4α,24-dimethyl-5α-cholest-24(28)-en-3β-ol, followed by reduction to 4α,24-dimethyl-5α-cholestan-3β-ol, then introduction of the Δ22-double bond to form 4α,24-dimethyl-5α-cholest-22E-en-3β-ol and then methylation at C-23 to form 4α23,24-trimethyl- 5α-cholest-22E-en-3β-ol (dinosterol).
Major Charles Karu Singleton, The Princess of Wales's Royal Regiment, 565366. Staff Sergeant Charlotte Louise Spence, Royal Army Physical Training Corps, W1060016. Major Jonathan Grant Studwell, Intelligence Corps, 30170101. Major Thomas Daniel Sweeney, Army Air Corps, 24757307. Sergeant Edward William Swindell, , Corps of Royal Engineers, Army Reserve, 30150063. Major Francesca Louise Sykes, Royal Regiment of Artillery, 30067880. Lieutenant Colonel Andrew James Teeton, Corps of Royal Engineers, 536346. Major (now Acting Lieutenant Colonel) James Viney, Corps of Royal Engineers, 25185183. Captain (now Acting Major) David Edward Williams, Corps of Royal Electrical and Mechanical Engineers, 24929032. Master Aircrew Oliver Martin Dewey, Royal Air Force, 30060196. Sergeant (now Acting Flight Sergeant) George Joseph Downey, Royal Air Force, L8516771. Wing Commander Sam Haley, Royal Air Force, 30000089. Squadron Leader James Duncan Hemingfield, Royal Air Force, 8700294K. Sergeant Martin John Henderson, Royal Air Force, 30112261. Squadron Leader Sharon Ingle, Royal Air Force, 30091084. Flight Sergeant (now Acting Warrant Officer) Stewart Marcus Jackson, Royal Air Force, F8427999. Flight Sergeant Philip Kipling, Royal Air Force, D8411323. Squadron Leader Kevin Charles William March, Royal Air Force, 30035301. Squadron Leader Christopher Scott Middleton, Royal Air Force, 2642751S. Squadron Leader Mark Shipley, Royal Air Force, 30001963. Warrant Officer Garry John Stanton, Royal Air Force, K8421673.
Mass change = (unbound system calculated mass) − (measured mass of system) e.g. (sum of masses of protons and neutrons) − (measured mass of nucleus) After a nuclear reaction occurs that results in an excited nucleus, the energy that must be radiated or otherwise removed as binding energy in order to decay to the unexcited state may be in one of several forms. This may be electromagnetic waves, such as gamma radiation; the kinetic energy of an ejected particle, such as an electron, in internal conversion decay; or partly as the rest mass of one or more emitted particles, such as the particles of beta decay. No mass deficit can appear, in theory, until this radiation or this energy has been emitted and is no longer part of the system. When nucleons bind together to form a nucleus, they must lose a small amount of mass, i.e. there is a change in mass to stay bound. This mass change must be released as various types of photon or other particle energy as above, according to the relation E = mc2. Thus, after the binding energy has been removed, binding energy = mass change × c2. This energy is a measure of the forces that hold the nucleons together. It represents energy that must be resupplied from the environment for the nucleus to be broken up into individual nucleons. For example, an atom of deuterium has a mass defect of 0.0023884 Da, and its binding energy is nearly equal to 2.23 MeV. This means that energy of 2.23 MeV is required to disintegrate an atom of deuterium.
=== Adverse effects === DNP has a low therapeutic index, meaning that the dosage at which toxicity occurs is not much larger than that required to produce a desired effect. Individual tolerance to DNP's harmful short- and long-term effects varies greatly. The most common adverse effect reported is a rash, which could be maculopapular, urticarial, angioedema, or an exfoliative dermatitis. Cataracts can form, causing a permanent loss of vision in days to months of usage, and permanent deafness has also been reported. Other adverse effects reported include peripheral neuritis, agranulocytosis, and neutropaenia. Negative effects on the central nervous system, cardiovascular system, and bone marrow can occur. In animal studies, DNP acted as a teratogen, mutagen, and carcinogen and caused developmental and reproductive harm. An unusually yellow coloring of the skin, mucous membranes, sclera, urine, stomach contents, and internal organs is an indication of DNP exposure, but does not occur in every case. Contact with skin or inhalation can cause DNP poisoning. Symptoms are typically mild with dermal exposure, but inhalation can lead to systemic effects, the same way as oral exposure.
Sources: en.wikipedia.org
Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.
Liquid chromatography coupled to mass spectrometry is the most common approach because it combines a retention time with a mass measurement. A chromatographic peak alone cannot establish which peptide is present, so mass determination or amino acid analysis is used as an orthogonal confirmation alongside the separation.
This depends on buffer, pH, and concentration, and published stability data for this peptide are limited. In practice laboratories work through a refrigerated solution within a few weeks and discard samples that show cloudiness or visible particles. Freezing and thawing repeatedly is generally discouraged.
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.